Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Nikitin, Pavel A ^a   Price, Alexander M ^a   McFadden, Karyn ^a   Yan, Christopher M ^a   Luftig, Micah A ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CASPASE 3; CASPASE 7; CD40 LIGAND; CHECKPOINT KINASE 2; CPG OLIGODEOXYNUCLEOTIDE; INTERLEUKIN 4; TOLL LIKE RECEPTOR 9;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DNA DAMAGE; DNA DAMAGE RESPONSE; EPSTEIN BARR VIRUS; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; SIGNAL TRANSDUCTION;

ANTIGENS, CD40; ATAXIA TELANGIECTASIA MUTATED PROTEINS; B-LYMPHOCYTES; CELL PROLIFERATION; CHECKPOINT KINASE 2; DNA DAMAGE; G1 PHASE CELL CYCLE CHECKPOINTS; HUMANS; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MITOGENS; S PHASE CELL CYCLE CHECKPOINTS; SIGNAL TRANSDUCTION;

EID: 84900450027     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087299     Document Type: Article

References (42)

1. Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R (2010) Control systems and decision making for antibody production. Nat Immunol 11: 681-688.
2. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, et al. (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 229: 152-172.
3. Cahir McFarland ED, Izumi KM, Mosialos G (1999) Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB. Oncogene 18: 6959-6964.
4. Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, et al. (1995) Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2: 155-166.
5. Kolar GR, Mehta D, Pelayo R, Capra JD (2007) A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood 109: 2545-2552. (Pubitemid 46425900)
6. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
7. Pape KA, Kouskoff V, Nemazee D, Tang HL, Cyster JG, et al. (2003) Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J Exp Med 197: 1677-1687. (Pubitemid 36745343)
8. Toellner KM, Gulbranson-Judge A, Taylor DR, Sze DM, MacLennan IC (1996) Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B cell activation. J Exp Med 183: 2303-2312. (Pubitemid 26158921)
9. Daniel JA, Nussenzweig A (2013) The AID-induced DNA damage response in chromatin. Mol Cell 50: 309-321.
10. Hasbold J, Corcoran LM, Tarlinton DM, Tangye SG, Hodgkin PD (2004) Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation. Nat Immunol 5: 55-63. (Pubitemid 38081469)
11. Ranuncolo SM, Polo JM, Dierov J, Singer M, Kuo T, et al. (2007) Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol 8: 705-714. (Pubitemid 46965346)
12. Townsend MJ, Monroe JG, Chan AC (2010) B-cell targeted therapies in human autoimmune diseases: an updated perspective. Immunol Rev 237: 264-283.
13. Kuppers R, Klein U, Hansmann ML, Rajewsky K (1999) Cellular origin of human B-cell lymphomas. N Engl J Med 341: 1520-1529. (Pubitemid 29526356)
14. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637. (Pubitemid 44864442)
15. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638-642. (Pubitemid 44864443)
16. Halazonetis TD, Gorgoulis VG, Bartek J (2008) An oncogene-induced DNA damage model for cancer development. Science 319: 1352-1355. (Pubitemid 351354863)
17. Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, et al. (2000) DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287: 1824-1827.
18. Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27: 247-254. (Pubitemid 32201842)
19. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913. (Pubitemid 40559004)
20. Maclean KH, Dorsey FC, Cleveland JL, Kastan MB (2008) Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. J Clin Invest 118: 79-88.
21. Hirao A, Cheung A, Duncan G, Girard PM, Elia AJ, et al. (2002) Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. Mol Cell Biol 22: 6521-6532.
22. McPherson JP, Lemmers B, Hirao A, Hakem A, Abraham J, et al. (2004) Collaboration of Brca1 and Chk2 in tumorigenesis. Genes Dev 18: 1144-1153. (Pubitemid 38669035)
23. Tort F, Hernandez S, Bea S, Martinez A, Esteller M, et al. (2002) CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas. Blood 100: 4602-4608. (Pubitemid 35429704)
24. Nikitin PA, Yan CM, Forte E, Bocedi A, Tourigny JP, et al. (2010) An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe 8: 510-522.
25. Hartmann G, Krieg AM (2000) Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 164: 944-953.
26. Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, et al. (2006) TLR9 activation is defective in common variable immune deficiency. J Immunol 176: 1978-1987. (Pubitemid 43134344)
27. Hawkins ED, Turner ML, Dowling MR, van Gend C, Hodgkin PD (2007) A model of immune regulation as a consequence of randomized lymphocyte division and death times. Proc Natl Acad Sci U S A 104: 5032-5037. (Pubitemid 47186171)
28. O'Nions J, Allday MJ (2004) Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens. J Gen Virol 85: 881-895. (Pubitemid 38489554)
29. Arienti KL, Brunmark A, Axe FU, McClure K, Lee A, et al. (2005) Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles. J Med Chem 48: 1873-1885. (Pubitemid 40396318)
30. Sato K, Ohta T, Venkitaraman AR (2010) A mitotic role for the DNA damage-responsive CHK2 kinase. Nat Cell Biol 12: 424-425.
31. Bartek J, Bartkova J, Lukas J (2007) DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26: 7773-7779. (Pubitemid 350242463)
32. Altmann M, Hammerschmidt W (2005) Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol 3: e404.
33. Rodier F, Munoz DP, Teachenor R, Chu V, Le O, et al. (2011) DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J Cell Sci 124: 68-81.
34. Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, et al. (2011) Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 13: 292-302.
35. Skalska L, White RE, Franz M, Ruhmann M, Allday MJ (2010) Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog 6: e1000951.
36. Maruo S, Zhao B, Johannsen E, Kieff E, Zou J, et al. (2011) Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci U S A 108: 1919-1924.
37. Skalska L, White RE, Parker GA, Sinclair AJ, Paschos K, et al. (2013) Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog 9: e1003187.
38. Markham JF, Wellard CJ, Hawkins ED, Duffy KR, Hodgkin PD (2010) A minimum of two distinct heritable factors are required to explain correlation structures in proliferating lymphocytes. J R Soc Interface 7: 1049-1059.
39. Price AM, Tourigny JP, Forte E, Salinas RE, Dave SS, et al. (2012) Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-kappaB activation. J Virol 86: 11096-11106.
40. Tsujimoto Y, Cossman J, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443. (Pubitemid 15041322)
41. Ngo VN, Young RM, Schmitz R, Jhavar S, Xiao W, et al. (2011) Oncogenically active MYD88 mutations in human lymphoma. Nature 470: 115-119.
42. Green NM, Marshak-Rothstein A (2011) Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol 23: 106-112.